Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933567 · ClinicalTrials.gov registry record · NA
CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care
A NA study of Psychosis, sponsored by Center for Social Innovation, Massachusetts.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02933567: Completed NA study of Psychosis, sponsored by Center for Social Innovation, Massachusetts.
NCT02933567 is a NA study of Psychosis that has completed, run by Center for Social Innovation, Massachusetts. The registered enrollment target is 16 participants, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02933567, a NA study of Psychosis, has completed, sponsored by Center for Social Innovation, Massachusetts.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) has partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care. The product builds on the findings of the Recovery After an Initial Schizophrenia Episode (RAISE) studies, funded by the National Institute of Mental Health (NIMH). RAISE examined team-based models of care for people early in the course of schizophrenia. Through a Fast Track Small Business Innovation Research (SBIR) grant, investigators will prototype, test, refine, and evaluate the impact of CSC OnDemand.
Primary Outcome
Participants will be tested on preliminary effectiveness of the CSC OnDemand tool.
Conditions Studied
Interventions
- OTHER CSC OnDemand
Study Locations (1)
Massachusetts
- Center for Social Innovation - Needham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-08-15 |
| Phase | NA |
What the finished NCT02933567 record still lists
NCT02933567 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 1 intervention - of which CSC OnDemand is the first listed.
NCT02933567 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02933567 about?
NCT02933567 is a clinical study titled "CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care". In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) has partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated...
What is the current status of trial NCT02933567?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-11. Estimated completion is 2017-08-15.
What conditions does trial NCT02933567 study?
This clinical trial studies the following conditions: Psychosis.
What interventions are being tested in trial NCT02933567?
The interventions under investigation include: CSC OnDemand (OTHER).
Who is sponsoring clinical trial NCT02933567?
This trial is sponsored by Center for Social Innovation, Massachusetts, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02933567 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02933567's enrollment target sits among peer trials
16 34th of 35 higher than 2 of 35 other Psychosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psychosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
RECRUITING · NA
-
Determining the Role of Social Reward Learning in Social Anhedonia
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
RECRUITING · NA
-
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia